Hookipa Pharma Announced That The Journal Of Infectious Diseases Has Published Preclinical Data On HB-400, An Investigational Therapeutic Vaccine For Chronic Hepatitis B Developed In Collaboration With Gilead Sciences
Benzinga Newsdesk - Oct 18, 2023, 7:05AM